Fumarate hydratase-deficient renal cell carcinoma in extended remission with bevacizumab and erlotinib
{{output}}
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant syndrome associated with fumarate hydratase (FH) gene mutation leading to defective DNA double-strand break repair mechanism. Although these tumours have an aggressive presenta... ...